Claudia A. Benavente

1.7k total citations
24 papers, 709 citations indexed

About

Claudia A. Benavente is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Claudia A. Benavente has authored 24 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Ophthalmology. Recurrent topics in Claudia A. Benavente's work include Epigenetics and DNA Methylation (8 papers), Cancer-related Molecular Pathways (8 papers) and Ocular Oncology and Treatments (7 papers). Claudia A. Benavente is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer-related Molecular Pathways (8 papers) and Ocular Oncology and Treatments (7 papers). Claudia A. Benavente collaborates with scholars based in United States, Chile and Israel. Claudia A. Benavente's co-authors include Elaine L. Jacobson, Michael A. Dyer, Stephanie Wu, Stephanie A. Schnell, Myron K. Jacobson, Sigvard Kopp, Per Alstergren, Loredana Zocchi, Michael L. Drummond and Guadalupe Gutierrez and has published in prestigious journals such as Nature Communications, PLoS ONE and Development.

In The Last Decade

Claudia A. Benavente

23 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia A. Benavente United States 15 376 209 103 97 78 24 709
Ning Yin China 13 452 1.2× 145 0.7× 47 0.5× 181 1.9× 54 0.7× 44 699
Rei Nakamura United States 13 621 1.7× 100 0.5× 249 2.4× 100 1.0× 197 2.5× 17 1.1k
Zaher Nahlé United States 13 1.0k 2.8× 449 2.1× 68 0.7× 269 2.8× 69 0.9× 18 1.4k
Mariela C. Marazita Argentina 12 350 0.9× 182 0.9× 101 1.0× 80 0.8× 61 0.8× 17 588
Guangbo Liu China 11 606 1.6× 129 0.6× 122 1.2× 173 1.8× 75 1.0× 17 1.0k
Yuanyuan Ling China 6 343 0.9× 73 0.3× 10 0.1× 71 0.7× 201 2.6× 10 872
Jean-Philippe Coppé United States 6 582 1.5× 189 0.9× 8 0.1× 155 1.6× 237 3.0× 7 1.1k
Nicolas Malaquin Canada 16 545 1.4× 188 0.9× 7 0.1× 112 1.2× 247 3.2× 20 1.0k
Jeff S. Pawlikowski United States 12 600 1.6× 204 1.0× 11 0.1× 119 1.2× 251 3.2× 16 1.1k
Carolina Pinzon‐Guzman United States 7 518 1.4× 148 0.7× 12 0.1× 111 1.1× 104 1.3× 13 802

Countries citing papers authored by Claudia A. Benavente

Since Specialization
Citations

This map shows the geographic impact of Claudia A. Benavente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia A. Benavente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia A. Benavente more than expected).

Fields of papers citing papers by Claudia A. Benavente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia A. Benavente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia A. Benavente. The network helps show where Claudia A. Benavente may publish in the future.

Co-authorship network of co-authors of Claudia A. Benavente

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia A. Benavente. A scholar is included among the top collaborators of Claudia A. Benavente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia A. Benavente. Claudia A. Benavente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yijun & Claudia A. Benavente. (2024). Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer. Journal of Clinical Medicine. 13(11). 3120–3120. 1 indexed citations
2.
Benavente, Claudia A., et al.. (2024). Oncogenic Roles of UHRF1 in Cancer. Epigenomes. 8(3). 26–26. 6 indexed citations
3.
Benavente, Claudia A., et al.. (2024). Abstract PR04: USP7 inhibitors prevent triple negative breast cancer metastasis by inducing UHRF1 protein degradation. Cancer Research. 84(3_Supplement_1). PR04–PR04. 1 indexed citations
4.
Chen, Claire C. & Claudia A. Benavente. (2024). Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential. International Journal of Molecular Sciences. 25(1). 568–568.
5.
Wu, Stephanie, Yijun Gu, Loredana Zocchi, et al.. (2022). UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression. Oncogenesis. 11(1). 51–51. 14 indexed citations
6.
Benavente, Claudia A. & Loredana Zocchi. (2021). DNA repair and epigenetic regulation in cancer. eScholarship (California Digital Library). 1 indexed citations
7.
Zocchi, Loredana, Aditi Mehta, Stephanie Wu, et al.. (2020). Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression. Oncogenesis. 9(2). 25–25. 30 indexed citations
8.
Wang, Shuxiong, Michael L. Drummond, Christian F. Guerrero‐Juarez, et al.. (2020). Single cell transcriptomics of human epidermis identifies basal stem cell transition states. Nature Communications. 11(1). 4239–4239. 135 indexed citations
9.
Zocchi, Loredana, Stephanie Wu, & Claudia A. Benavente. (2020). Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 7(3-4). 23–25. 4 indexed citations
10.
Zocchi, Loredana, et al.. (2018). The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Oncotarget. 9(34). 23505–23518. 31 indexed citations
11.
Benavente, Claudia A. & Michael A. Dyer. (2015). Genetically Engineered Mouse and Orthotopic Human Tumor Xenograft Models of Retinoblastoma. Methods in molecular biology. 1267. 307–317. 3 indexed citations
12.
Benavente, Claudia A. & Michael A. Dyer. (2015). Genetics and Epigenetics of Human Retinoblastoma. Annual Review of Pathology Mechanisms of Disease. 10(1). 547–562. 103 indexed citations
13.
Benavente, Claudia A., David Finkelstein, Dianna A. Johnson, et al.. (2014). Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget. 5(20). 9594–9608. 31 indexed citations
14.
Benavente, Claudia A., Stephanie A. Schnell, & Elaine L. Jacobson. (2012). Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin. PLoS ONE. 7(7). e42276–e42276. 53 indexed citations
15.
Bermudez, Yira, et al.. (2011). Nicotinic Acid Receptor Abnormalities in Human Skin Cancer: Implications for a Role in Epidermal Differentiation. PLoS ONE. 6(5). e20487–e20487. 28 indexed citations
16.
Benavente, Claudia A., Myron K. Jacobson, & Elaine L. Jacobson. (2009). NAD in Skin: Therapeutic Approaches for Niacin. Current Pharmaceutical Design. 15(1). 29–38. 40 indexed citations
17.
Benavente, Claudia A. & Elaine L. Jacobson. (2007). Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free Radical Biology and Medicine. 44(4). 527–537. 56 indexed citations
18.
Benavente, Claudia A.. (2007). CELLULAR NAD STATUS AS A REGULATOR OF SKIN PHOTODAMAGE. UA Campus Repository (The University of Arizona). 1 indexed citations
19.
Benavente, Claudia A., Walter Sierralta, Paulette Conget, & José J. Minguell. (2003). Subcellular Distribution and Mitogenic Effect of Basic Fibroblast Growth Factor in Mesenchymal Uncommitted Stem Cells. Growth Factors. 21(2). 87–94. 31 indexed citations
20.
Alstergren, Per, Claudia A. Benavente, & Sigvard Kopp. (2003). Interleukin-1β, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. Journal of Oral and Maxillofacial Surgery. 61(10). 1171–1178. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026